SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-10.1
Date Filed: 2025-06-04
Accession Number: 0001213900-25-050984
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025050984/ea024464201ex10-1_synergy.htm

Chunk 33 of 63
Word Count: 1459
Character Count: 9249

Document Content:

of their rights and remedies under the Loan Documents and applicable law with respect to the Collateral, including, without limitation, any foreclosure, sale, transfer or other enforcement right of or with respect to the Collateral; provided that any such sale or transfer of the Intellectual Property associated with the Licensed Products shall be made subject to the license granted in favor of Knight pursuant to the Knight Agreement; (f) within ten (10) Business Days after the Effective Date (or such longer period as the Agents may agree in their sole discretion), deliver to the Agents (i) evidence that Hand MD Corp. has been reinstated and is in good standing with the Delaware Secretary of State and (ii) executed copies of such agreements, instruments and other documents required by Section 7.1(b), in each case with respect to the foregoing clauses (i) and (ii), in form and substance satisfactory to the Agents;

(g) within
five (5) Business Days after the Effective Date (or such longer period as the Collateral Agent may agree in its sole discretion), deliver
evidence satisfactory to the Agents that the Canadian Guarantor has filed the required registration under the Extra-Provincial Corporations
Act (Ontario), to the extent required under applicable law; and

(h) within
five (5) Business Days after the Effective Date (or such longer period as the Collateral Agent may agree in its sole discretion), deliver
to the Collateral Agent evidence of the filing of a UCC-3 termination statement with respect to the UCC-1 financing statement (Initial
Filing Number 2024402520-9) filed on May 1, 2024 with the Nevada Secretary of State by Middesk, Inc. as secured party against the Borrower
as debtor; and

(i) within
five (5) Business Days after the Effective Date (or such longer period as the Collateral Agent may agree in its sole discretion), deliver
evidence satisfactory to the Agents that the Borrower has filed the required transfer of all Registered Intellectual Property in the name
of any predecessor in interest with CIPO or the United States Patent and Trademark Office, as applicable, and with respect to such Registered
Intellectual Property in the United States, an executed Intellectual Property Security Agreement to be filed with the United States Patent
and Trademark Office and, forthwith upon receipt of confirmation from CIPO and the United States Patent and Trademark Office that such
Registered Intellectual Property was successfully transferred to the Borrower, evidence of such completed transfers, provided further
that the Collateral Agent shall thereafter be irrevocably authorized and directed to register its security interest in such Registered
Intellectual Property with CIPO in accordance with the Canadian Security Documents and to complete any and all ancillary documents in
connection therewith.

Article

REPRESENTATIONS AND WARRANTIES

Section 6.1. Representations
and Warranties. Each Loan Party hereby represents and warrants to the Secured Parties as follows:

(a) Organization,
Good Standing, Etc. Each Loan Party (i) is a corporation, limited liability company or limited partnership duly organized, validly
existing and in good standing under the laws of the state or jurisdiction of its organization, (ii) has all requisite power and authority
to conduct its business as now conducted and as presently contemplated and, in the case of the Borrower, to make the borrowings hereunder,
and to execute and deliver each Loan Document to which it is a party, and to consummate the transactions contemplated thereby, and (iii)
is duly qualified to do business and is in good standing in each jurisdiction in which the character of the properties owned or leased
by it or in which the transaction of its business makes such qualification necessary, except (solely for the purposes of this subclause
(iii)) where the failure to be so qualified and in good standing could not reasonably be expected to have a Material Adverse Effect.

(b) Authorization,
Etc. The execution, delivery and performance by each Loan Party of each Loan Document to which it is or will be a party, (i) have
been duly authorized by all necessary action, (ii) do not and will not contravene (A) any of its Governing Documents, (B) any applicable
Requirement of Law or (C) any material Contractual Obligation binding on or otherwise affecting it or any of its properties (including
the Material Contracts) by which such Loan Party is bound, (iii) do not and will not result in or require the creation of any Lien (other
than pursuant to any Loan Document) upon or with respect to any of its properties, and (iv) do not and will not result in any default,
noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal of any permit, license, authorization or approval applicable
to its operations or any of its properties, except, in the case of clauses (ii)(B), (ii)(C) and (iv), to the extent where such contravention,
default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal could not reasonably be expected to have a Material
Adverse Effect.

(c) Governmental
Approvals. No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required
in connection with the due execution, delivery and performance by any Loan Party of any Loan Document to which it is or will be a party
other than (i) filings and recordings with respect to Collateral to be made, or otherwise delivered to the Collateral Agent for filing
or recordation, on the Effective Date or (ii) such as have been obtained and are in full force and effect.

(d) Enforceability
of Loan Documents. This Agreement is, and each other Loan Document to which any Loan Party is or will be a party, when delivered hereunder,
will be, a legal, valid and binding obligation of such Person, enforceable against such Person in accordance with its terms, except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement
of creditors’ rights generally and by general principles of equity.

(e) Capitalization.
On the Effective Date, after giving effect to the transactions contemplated hereby to occur on the Effective Date, the authorized Equity
Interests of the Borrower and each of its Subsidiaries and the issued and outstanding Equity Interests of the Borrower and each of its
Subsidiaries are as set forth on Schedule 6.1(e) hereto. All of the issued and outstanding shares of Equity Interests of the Borrower
and each of its Subsidiaries have been validly issued and are fully paid and nonassessable, and the holders thereof are not entitled to
any preemptive, first refusal or other similar rights. All Equity Interests of such Subsidiaries of the Borrower are owned by the Borrower
free and clear of all Liens (other than Permitted Specified Liens). Except as described on Schedule 6.1(e) hereto, there are no outstanding
debt or equity securities of the Borrower or any of its Subsidiaries and no outstanding obligations of the Borrower or any of its Subsidiaries
convertible into or exchangeable for, or warrants, options or other rights for the purchase or acquisition from the Borrower or any of
its Subsidiaries, or other obligations of the Borrower or any of its Subsidiaries to issue, directly or indirectly, any shares of Equity
Interests of the Borrower or any of its Subsidiaries.

(f) Litigation.
Except as set forth on Schedule 6.1(f), there is no pending or, to the knowledge of any Loan Party, threatened action, suit or proceeding
affecting any Loan Party or any of its properties before any court or other Governmental Authority or any arbitrator that (i) could reasonably
be expected to have a Material Adverse Effect or (ii) relates to this Agreement or any other Loan Document or any transaction contemplated
hereby or thereby.

(g) Financial
Statements.

(i) The
Financial Statements, copies of which have been delivered to each Agent and each Lender, fairly present the consolidated financial condition
of the Borrower and its Subsidiaries as at the respective dates thereof and the consolidated results of operations of the Borrower and
its Subsidiaries for the fiscal periods ended on such respective dates, all in accordance with GAAP. All material indebtedness and other
liabilities (including, without limitation, Indebtedness, liabilities for taxes, long-term leases and other unusual forward or long-term
commitments), direct or contingent, of the Borrower and its Subsidiaries are set forth in the Financial Statements. Since December 31,
2024, no event or development has occurred that has had or could reasonably be expected to have a Material Adverse Effect.

(ii) The
Borrower has heretofore furnished to each Agent and each Lender (A) projected monthly balance sheets, income statements and statements
of cash flows of the Borrower and its Subsidiaries for the Fiscal Year 2025, and (B) projected quarterly balance sheets, income statements
and statements of cash flows of the Borrower and its Subsidiaries for the Fiscal Years 2026 through 2028 which projected financial statements
shall be updated from time to time pursuant to Section 7.1(a)(vi).